{
    "url_original": "https://www.wsj.com/articles/pfizer-biontech-covid-19-booster-authorized-for-16-and-17-year-olds-11639067421?mod=business_lead_pos7",
    "url": "pfizer-biontech-covid-19-booster-authorized-for-16-and-17-year-olds-11639067421",
    "title": "Pfizer-BioNTech Covid-19 Booster Authorized for 16- and 17-Year-Olds",
    "sub_head": "The teenagers can now get the extra dose at least six months after finishing the two-dose series",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-12-09 16:18:00",
    "body": "U.S. health regulators cleared the Covid-19 booster from  Pfizer Inc.  and partner  BioNTech  SE for use in 16- and 17-year-olds, widening eligibility as the worrisome Omicron variant spreads around the world.<br />The Food and Drug Administration decision permits the teenagers to receive a third dose of the shot at least six months after their primary vaccination series."
}